Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 121-140 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 121 | Azista Industries Private Limited lowweak | Opp 3 Risk 2 | Thesis: Reviewed evidence rationale says Azista Industries successfully imaged the ISS using its AFR satellite and notes potential uses in space situational awareness and missile monitoring. If current, successful imaging and dual-use application potential support a modest 1 year+ opportunity case. Why now: The only support cited is article in the membership rationale. Because the company coverage report shows zero articles after recent evidence window and zero evidence after recent evidence window, there is no robust timing catalyst beyond the historical demonstration narrative. Caveats: Single-article support only, and not available as active evidence. No direct evidence on customer conversion, regulatory adoption, or funding. Private-company visibility is limited in these reviewed sources. |
| 122 | Bellatrix Aerospace lowweak | Opp 3 Risk 2 | Thesis: Reviewed evidence membership rationale describes Bellatrix Aerospace as a space propulsion company partnering on a VLEO satellite mission using its air-breathing electric propulsion platform. If current, that points to differentiated technology and a potentially durable 1-year-plus opportunity setup, but the reviewed sources lack citeable direct evidence or article. Why now: Why now is only moderate in theory because propulsion/platform partnerships can matter over a 1-year-plus horizon, but these reviewed sources does not provide recency-anchored evidence after recent evidence window. Caveats: No direct evidence with available for citation. Technology differentiation is only inferred from membership rationale and is not independently corroborated in available evidence. |
| 123 | D-Orbit lowweak | Opp 3 Risk 2 | Thesis: D-Orbit appears strategically positioned in space logistics and in-orbit servicing, with reviewed sources rationale referencing an ESA award and supporting context noting prior Series D funding, but the retained in-window evidence is weak and mostly undated context. Why now: Why-now is weak because retained evidence after recent evidence window is mostly undated context; one cited article is from February 14, 2026 and therefore outside the 90-day evidence window, while the remaining available context is undated. Evidence
Caveats: Reviewed evidence membership rationale mentions a €119 million ESA contract, but no citeable retained row for that contract is included here. Series D funding mention is in a February 14, 2026 article outside the 90-day recent evidence window. Undated context is not recency proof. |
| 124 | Fujitsu lowweak | Opp 3 Risk 1 | Thesis: Fujitsu has a plausible long-horizon opportunity angle because the reviewed sources' membership rationale says it signed an MOU with BULL to develop a high-precision space situational awareness service for Japan. That suggests direct participation in an SDA-related service, but the reviewed sources still frames Fujitsu primarily as a large IT/services company and provides no direct positive evidence row or after recent evidence window (: and; not provided in reviewed sources). Why now: An MOU in SDA could matter over a 1 year+ horizon if it converts into deployments or service revenue, but the reviewed sources offers no direct dated evidence inside recent evidence window and no article to validate timing. Caveats: Large diversified company; reviewed sources does not show materiality of space effort. MOU is weaker than signed commercial contract revenue evidence. No direct article content or is available in reviewed sources. |
| 125 | GalaxySpace lowweak | Opp 3 Risk 2 | Thesis: GalaxySpace has some strategic optionality because the reviewed sources say it set up a space computing research institute and places it in space computing and satellite communications context, but that is early and not enough for a strong opportunity call. Why now: The reviewed sources references article: for the research institute setup, yet does not provide the article or direct event details to assess timing or commercial conversion. Caveats: Only one article is considered and no representative article object is provided. Research institute formation is weaker than product, contract, or financing milestones. Commercial impact timing is unclear. |
| 126 | Gate Space lowweak | Opp 3 Risk 2 | Thesis: Gate Space has a modest opportunity case because an undated supporting article context item says it won 6.3 million euros in funding from a government-backed accelerator program, which could support longer-horizon development if still current Why now: For a 1 year+ horizon, funding can matter, but recency is uncertain because the article is explicitly undated and the reviewed sources say undated external evidence is relevance context rather than recency proof Evidence
Caveats: The evidence is weak context and supporting article context, not direct structured company event/fact evidence. The article is undated; the reviewed sources explicitly says recency-sensitive claims should be treated cautiously. Same-article repeated rows are not independent confirmation. |
| 127 | Globalstar lowweak | Opp 3 Risk 4 | Thesis: Globalstar's cohort fit as a satellite communications and direct-to-device company is clear from the membership rationale, but these reviewed sources provide no in-window direct evidence to support a stronger opportunity ranking. Why now: There is effectively no why-now evidence in this row: the recent evidence review shows zero kept rows after the March 29, 2026 cutoff and no representative articles are provided. Caveats: The phase-2 rationale mentions Amazon acquisition-related articles, but those supporting articles are not included in the available evidence for this row. Scores remain low because absence of evidence is not positive evidence. |
| 128 | Goonhilly Earth Station Ltd lowweak | Opp 3 Risk 3 | Thesis: Among this screen, Goonhilly has the strongest stated strategic relevance because the reviewed sources' membership rationale says it has ground-station/COMSAT revenue and is involved in a transaction with Intuitive Machines, implying potentially durable space-infrastructure relevance over a 1 year+ horizon. However, the reviewed sources provide no retained direct evidence or article summaries to verify timing or terms, so the opportunity case remains weak. Why now: The only 'why now' available is the reviewed sources' statement that Goonhilly is being acquired by Intuitive Machines, cited in phase-2 support, and: but no, timestamps, or retained evidence are provided, so recency and sequence cannot be validated. Caveats: The reviewed sources rationale states Goonhilly has ground-station/COMSAT revenue and is being acquired by Intuitive Machines, tied to, and: but no or retained evidence are present. Coverage debug still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Because chronology cannot be verified, transaction-state claims should be treated cautiously. |
| 129 | GS Yuasa Corporation lowweak | Opp 3 Risk 1 | Thesis: GS Yuasa has the cleanest stated product adjacency in the reviewed sources because the membership rationale says it is listed as a key player in a space battery market report. If that positioning reflects real participation in spacecraft power systems, it could matter over a 1 year+ horizon; however, the reviewed sources provide no retained direct evidence or dated summaries, so the opportunity score remains modest. Why now: There is no verified near-term catalyst, but the reviewed sources' phase-2 rationale references saying GS Yuasa was named as a key player in a space battery market report. Without, timing detail, or retained evidence, recency is uncertain. Caveats: The rationale cites, but no or retained article text is provided. Being listed as a key player in a market report is weaker than direct contract, launch, or financial evidence. No retained evidence remain after the 90-day recent evidence window. |
| 130 | HEO lowweak | Opp 3 Risk 2 | Thesis: Possible long-horizon opportunity from being listed as operating and from an undated mention of a seven-figure BlackSky space domain awareness expansion contract for automated non-Earth imaging missions, but this is only supporting article context and recency is uncertain. Why now: Why now is weak because both cited items are undated, so the reviewed sources does not establish a fresh catalyst within the current evidence window. The only support is that HEO appears in current reviewed sources context as an operating company and as associated with a contract mention, but recency cannot be confirmed from the reviewed sources Evidence
Caveats: Both supporting items are undated, so recency is uncertain. Support is supporting article context, not stronger company-specific dated event evidence. Same-article repeated rows in the reviewed sources are not independent confirmation. |
| 131 | Hula Earth lowweak | Opp 3 Risk 1 | Thesis: There is a weak, article-level opportunity case that Hula Earth is an early-stage biodiversity monitoring platform using satellite imagery and that it had raised seed funding by the time of the cited profile, which could support long-horizon company development. However, this is not direct event/fact evidence in the reviewed sources; it is external article context only. Why now: The only dated retained context is a Startup Intros profile with April 16, 2026, stating Hula Earth uses IoT sensors and satellite imagery and had raised €1.6 million in seed funding; that is recent enough for a 1 year+ watchlist but too weak for a high-conviction thesis. Evidence
Caveats: Evidence is weak context and supporting article context, not direct company event/facts. The funding itself is described as having occurred in November 2024 inside an April 16, 2026 profile, so exact recency of the financing event is older than the profile date. Reviewed evidence itself says Earth observation fit is plausible but not strong from these reviewed sources alone. |
| 132 | HyPrSpace lowweak | Opp 3 Risk 4 | Thesis: HyPrSpace has some long-horizon upside as a launch startup because the reviewed sources membership rationale says it raised a €21M Series A and is developing hybrid propulsion for a small launch vehicle and suborbital prototype. Why now: The reviewed sources does not provide recent evidence window-supported article details for the cited raise and development milestones, so the timing case is under-evidenced. Caveats: No representative articles or direct evidence are available after recent evidence filtering. The opportunity view rests only on the membership rationale rather than article-level evidence available for citation. |
| 133 | Institute for Q-shu Pioneers of Space, Inc (iQPS) lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources say iQPS is a private Japanese Earth-imaging company whose QPS-SAR satellites are launched on Rocket Lab missions. That indicates a functioning path to deployment and a potentially scalable SAR imaging platform over a 1 year+ horizon. Why now: Why now is only modest because launch-linked deployment could matter over a long horizon, but there are no available article summaries or dated events to establish current momentum. Caveats: Membership rationale references article IDs and, but no or summaries are provided. No direct evidence survived or were available into these reviewed sources after recent evidence window. Do not use relation context as counterparty propagation evidence. |
| 134 | IonQ lowweak | Opp 3 Risk 3 | Thesis: IonQ has a possible strategic long-horizon opportunity if the reviewed sources' referenced Capella Space subsidiary linkage and SDA prototype agreement ultimately create material space exposure, but the reviewed sources does not allow straightforward propagation from subsidiary or relation context to IonQ itself without stronger direct evidence. Why now: Potential 'why now' would be the referenced space-subsidiary contract pathway, but recency and direct materiality to IonQ are not validated in available evidence for the 90-day recent evidence window. Caveats: Phase-2 rationale references and: but no or summaries are provided in the reviewed sources. Relations and counterparty propagation are not allowed by default. Coverage debug shows zero evidence after recent evidence window despite a large article universe. |
| 135 | ispace lowweak | Opp 3 Risk 4 | Thesis: The reviewed sources places ispace in private lunar mission context and notes 'ispace Hakuto-R,' which indicates continuing relevance in lunar mission execution if the program remains active. Why now: The membership support cites: and: The reviewed sources' wording around a second attempt makes mission outcome and execution durability relevant over a 1 year+ horizon, but timing confidence is reduced because no evidence survived into the available set. Caveats: Risk thesis is inferred from reviewed sources rationale mentioning a prior failure, not from available direct negative evidence. No direct evidence confirms current mission status, financing, or customer pipeline. Recency and sequencing of mission milestones cannot be validated from the empty evidence table. |
| 136 | Kepler Aerospace lowweak | Opp 3 Risk 3 | Thesis: Reviewed evidence context describes Kepler Aerospace as an Indian New Space startup operating a GSaaS network, integrating ground stations, and working on CubeSat platforms and satellite communications infrastructure. That breadth could support a 1 year+ infrastructure thesis, but there is no available in-window evidence of contracts, deployments, or financing progress. Why now: No current catalyst is established. Membership support references article ID: but the reviewed sources provide no and shows no evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Context includes relation/fact counts in support statistics, but relations are context-only and cannot be propagated as operating proof. |
| 137 | Kepler Communications lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources places Kepler Communications in space communications, HydRON network or optical communications context, and also notes it as an Nvidia space-AI customer. If accurate and current, those references could support a strategic network and onboard compute opportunity over 1 year+. Why now: The reviewed sources references, and: in membership support, suggesting recent strategic context, but no post-recent evidence window evidence are actually available for scoring. Caveats: Reviewed evidence itself says support is somewhat contextual. Context-only references are weaker than direct event/fact evidence. No available evidence confirms deployment, revenue, or funding milestones. |
| 138 | LiveEO lowweak | Opp 3 Risk 2 | Thesis: Reviewed evidence rationale says LiveEO secured ESA funding for the Twinspector satellite constellation for infrastructure monitoring, which could support a 1 year+ commercialization path, but there is no directly citable within the recent evidence window evidence in the reviewed sources. Why now: Why-now cannot be established because no evidence remain after recent evidence filtering. Caveats: Phase2 membership rationale references, but no summary or evidence are provided for citation. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low scores reflect missing usable evidence, not a bearish business judgment. |
| 139 | Mach Industries lowweak | Opp 3 Risk 2 | Thesis: Among this screen, Mach Industries has one of the stronger but still weakly grounded setups because the reviewed sources' membership rationale says it is a startup that raised $300 million and builds aerospace/defense systems including a 'Stratos satellite platform.' If accurate, that suggests longer-horizon capital availability and product ambition, but the reviewed sources provide no direct positive evidence row or after recent evidence window to validate scale, timing, or execution (: not provided in reviewed sources). Why now: For a 1 year+ horizon, a large raise and mention of a satellite platform could matter if recent, but the reviewed sources does not provide usable dated evidence within the 90-day recent evidence window and explicitly reports zero available evidence after recent evidence window. Caveats: No article provided in reviewed sources. No direct event/facts are available after recent evidence window despite the membership rationale referencing a raise. Primarily defense-tech framing may limit pure-play space thesis relevance. |
| 140 | Maxar Technologies Inc. lowweak | Opp 3 Risk 2 | Thesis: Maxar has some residual opportunity appeal because the membership rationale cites a specific $500 million NASA deal in a commercial satellite imaging market report, which would be material if current, but the reviewed sources includes no retained evidence row or recent article summary to validate status or timing now. Why now: No retained evidence is available within the reviewed sources despite the membership rationale referencing a prior NASA deal article. That makes the name a weak current candidate under local-evidence-only rules. Caveats: No retained article summary or dated event row is provided for the cited NASA deal. Cannot elevate conviction based only on membership rationale. |
Risk view
Showing rows 201-220 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 201 | QOSMIC lowweak | Opp 4 Risk 2 | Thesis: Main risk is execution and evidence uncertainty rather than a documented adverse event. The reviewed sources only provides undated supporting article context about a seed round and intended use of proceeds, which leaves recency, funding durability, and commercialization progress uncertain. Why now: Why now is weak because the only support is undated context articles; the reviewed sources explicitly says no is available, so recency-sensitive claims should be treated cautiously for these funding and expansion statements Evidence
Caveats: Evidence is undated; recency is uncertain. Support is supporting article context only, not direct structured positive event evidence. Same funding story appears in two articles and should not be treated as independent confirmation. |
| 202 | Quantum Space lowweak | Opp 4 Risk 2 | Thesis: The reviewed sources provide no retained article or evidence after recent evidence window to quantify contract size, award stage, revenue timing, or execution burden, so the opportunity is plausible but not well-validated and downside cannot be measured. Why now: The reviewed sources provide no post-recent evidence window detailed evidence, but the membership rationale specifically references selection for the Andromeda program via article. Because the underlying article summary/ is not included here, timing and magnitude are uncertain. Caveats: No representative article or is included for the cited Andromeda selection evidence. Selection for a program is positive, but without award size or timing the business impact is unclear. Scores are capped by missing direct article-level support. |
| 203 | Relativity Space lowweak | Opp 1 Risk 2 | Thesis: Risk is slightly higher than base because the company is described only through older membership rationale involving development of the Terran R reusable rocket and financing participation, without current evidence confirming execution progress, but this remains low-conviction because no direct negative evidence is retained. Why now: Why now is weak because there are no retained post-cutoff article summaries or evidence in the reviewed sources. Caveats: No retained evidence after recent evidence window. The modest risk uplift reflects uncertainty from lack of current confirmation, not a direct adverse event. |
| 204 | Reliance Industries Limited lowweak | Opp 2 Risk 2 | Thesis: There is also strategy-execution risk because the phase-2 rationale says the project is early stage with no final timeline or finalized investment, but again the reviewed sources does not provide retained article-level citations for those statements here, so risk remains low-scored due to weak grounding. Why now: Why now is weak because although the phase-2 rationale references articles, and: regarding LEO satellite communication plans, no or retained evidence are available and coverage data shows articles after recent evidence window of 0. Caveats: Phase-2 rationale suggests planning activity, not confirmed operating status, and cannot be cited as fact without /evidence. No representative articles or evidence are available after recent evidence window. Scores are constrained by insufficient retained evidence, not by a definitive neutral business view. |
| 205 | Remondo lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources supports some development-stage and timing risk because the cited milestone is still a planned future demonstration mission in 2027, but the evidence is old and sparse. Why now: The only concrete article summary is dated February 23, 2026 and therefore outside the 90-day recent evidence window cutoff of March 29, 2026; it says Remondo plans to launch its first mission in 2027 to demonstrate PAIS, which is interesting for long-horizon monitoring but not strong enough for a current thesis. Evidence
Caveats: All dated evidence was dropped by the 90-day recent evidence filter. Only one older article is available, so corroboration is limited. |
| 206 | Rhea Space Activity lowweak | Opp 2 Risk 2 | Thesis: Risk is mostly uncertainty from missing current evidence rather than explicit adverse developments. Without available direct evidence, it is hard to assess whether financing, product progress, or customer conversion remains on track. Why now: Why now is limited because no within the recent evidence window evidence were retained for ranking, so recency and durability cannot be tested. Caveats: Phase-2 membership rationale references, but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The financing claim cannot be elevated beyond low conviction without direct available evidence. |
| 207 | Rocket Factory Augsburg lowweak | Opp 1 Risk 2 | Thesis: As an apparent pre-launch rocket company, execution risk may be elevated, but the reviewed sources does not provide retained adverse evidence, so only a modest evidence-light risk score is justified. Why now: No retained article or event evidence remains after recent evidence filtering; the only hint is a membership rationale referencing first test-launch focus via article: without an included summary. Caveats: Cannot treat membership rationale alone as strong directional proof. No article summary or retained evidence row is included for article |
| 208 | Rocket One, Inc. lowweak | Opp 2 Risk 2 | Thesis: The same contextual pivot language also creates execution and qualification risk because the reviewed sources does not firmly establish Rocket One as a current operating space company in the target categories, and there is no direct post-recent evidence window evidence of contracts, product milestones, financing, or customer traction. Why now: Membership rationale cites articles, and: describing a renamed former biotech company pivoting toward space/defense AI chips and nano-launch or nanosatellite enablement, but coverage data still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources. Caveats: Context suggests strategic intent, not proven execution. No article are provided for cited membership-rationale articles. No direct evidence survive recent evidence filtering. |
| 209 | RTX Corporation lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is available in the reviewed sources for RTX, so there is no supported risk thesis from the provided evidence. Why now: Although the membership rationale references articles, and: the reviewed sources loads zero reviewed evidence after recent evidence filtering, so there is no directly scorable current catalyst from local evidence. Caveats: Very large article universe exists, but article count is not conviction. Membership support references potentially meaningful articles, but those summaries/evidence are not available here and therefore cannot be elevated into direct scoring evidence. |
| 210 | Satellogic Inc. lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is available, but there is also no current direct evidence to establish momentum or deterioration. Why now: Why-now support is absent because coverage data shows zero evidence after recent evidence window. Caveats: Phase2 rationale cites 2026-04, and: but no representative articles or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects missing current reviewed sources evidence rather than negative evidence. |
| 211 | SatixFy lowweak | Opp 2 Risk 2 | Thesis: No direct adverse evidence is available, but lack of current evidence means the reviewed sources cannot support a strong opportunity or risk thesis. Why now: The reviewed sources includes no representative article or evidence row inside the 90-day recent evidence window, so there is no dated near-current catalyst to anchor a 1 year+ view from this screen alone. Caveats: No retained evidence after recent evidence window. Referenced acquisition/shipment facts are only in the phase-2 rationale here, not in cited retained evidence. |
| 212 | SatSure Analytics India Pvt. Ltd. lowweak | Opp 2 Risk 2 | Thesis: The main risk is evidentiary: no direct adverse evidence is available, but there is also no in-window evidence confirming current execution, funding status, customer traction, or program progress, limiting confidence in any opportunity case. Why now: There is no reliable 'why now' catalyst in the available evidence. The reviewed sources notes support/article IDs were used for membership, but after the 90-day recent evidence filter there were 0 article IDs after recent evidence window and 0 evidence available, so recency is uncertain for any thesis. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs, and: but the reviewed sources does not provide or article summaries for citation. Without -bearing evidence, factual support is limited to reviewed sources-level membership rationale only. |
| 213 | SEALSQ Corp lowweak | Opp 1 Risk 2 | Thesis: Main risk is evidence opacity rather than explicit adverse business events: the reviewed sources show 47 articles considered but zero article IDs after recent evidence window and zero evidence available after dedupe, leaving business-state recency uncertain. Why now: Why now is weak because the 90-day reviewed sources contain no available evidence after recent evidence window for SEALSQ, despite article history existing in the broader corpus. Caveats: No direct positive or negative evidence available after recent evidence window. Membership rationale references article IDs and, but the reviewed sources provide no for them, so they cannot be cited as factual support under the the evidence standard. |
| 214 | SES mediummedium | Opp 6 Risk 2 | Thesis: The reviewed sources show no direct adverse evidence. Main risk is that the available evidence is supporting article context rather than a fuller company-specific contract filing, and one related transportation agreement is older than the recent evidence window. Why now: The key evidence is recent and within the recent evidence window: a June 11, 2026 SpaceNews article says SES was selected last month as a prime contractor under the PTS-G program, with K2 Space providing SES's satellite platform Evidence
Caveats: Reviewed evidence is still supporting article context rather than a direct company filing. The Impulse transportation agreement is older and outside the 90-day recent evidence window. |
| 215 | Sierra Nevada Corporation mediummedium | Opp 4 Risk 2 | Thesis: The main risk is evidentiary rather than operational: the reviewed sources itself says mapping between Sierra Nevada Corporation and Sierra Space is not fully explicit, and the surviving support is supporting article context rather than direct company events. Why now: The key surviving context is dated April 8, 2026, within the 90-day recent evidence window, and references recent contract awards under Andromeda that could matter over a 1 year+ horizon if they convert into meaningful program work. Article timestamp: April 8, 2026, basis: source date. Evidence is from at Evidence
Caveats: Evidence is supporting article context, not a direct structured positive event row for Sierra Nevada Corporation. Reviewed evidence explicitly notes entity-resolution ambiguity between Sierra Nevada Corporation and Sierra Space. The second representative article is older than the 90-day recent evidence window and should not drive recency, published September 2, 2025. |
| 216 | Sift lowweak | Opp 2 Risk 2 | Thesis: Risk is mainly thesis slippage risk: the company may be an enabling software layer rather than a direct space operator, and the reviewed sources contain no direct business traction or adverse evidence for ranking. Why now: Why now is weak because only article is referenced in the membership rationale, with no and no reviewed evidence to validate timing or materiality for the ranking horizon. Caveats: No article is available for article. Space exposure may be indirect rather than core. Coverage debug shows zero post-recent evidence window evidence. |
| 217 | Silicon Microgravity lowweak | Opp 2 Risk 2 | Thesis: Risk is mainly execution and information opacity risk because the reviewed sources lack direct dated rows on revenue, contracts, milestones, or setbacks. Why now: Why now is weak because the only support referenced is article: in the membership rationale, and the reviewed sources provide neither a nor a reviewed evidence row to substantiate timing beyond that summary. Caveats: No article is available for article Coverage debug shows zero post-recent evidence window evidence for ranking. Funding support alone, even if true, would not establish durable attractiveness without additional execution evidence. |
| 218 | SKY Perfect JSAT lowweak | Opp 3 Risk 2 | Thesis: The same evidence is weak for timing because it is undated supporting article context rather than direct event/fact evidence, so current economic significance and sequencing are uncertain Why now: This is one of the only companies in the screen with any current evidence surviving the recent evidence window, but it is undated supporting context, so why-now confidence is still limited Evidence
Caveats: Evidence is undated and supporting article context only. Same article appears in multiple weak-context rows and is not independent confirmation. No direct positive event/fact beyond supporting context. |
| 219 | Space Forge lowweak | Opp 2 Risk 2 | Thesis: Risk is primarily uncertainty and execution risk because no direct positive or negative rows are preserved in the ranking reviewed sources despite the membership rationale referencing funding and technology progress. Why now: Why now is weak because the reviewed sources cites articles: and: in the membership rationale, but no or reviewed evidence are provided for ranking-grade citation. Caveats: No article are provided for the referenced support articles. Cannot convert broad space-tech relevance into a strong opportunity thesis without direct evidence. Coverage after recent evidence window is empty. |
| 220 | SpaceLogistics (Northrop Grumman) lowweak | Opp 1 Risk 2 | Thesis: Primary risk in this ranking is stale evidence: there is no retained within the recent evidence window evidence to confirm current contracts, fleet expansion, or demand. That makes the near-current business state uncertain in these reviewed sources. Why now: Why now is weak because the only cited article, March 4, 2025), falls outside the 90-day recent evidence window and was dropped; recency therefore does not support an active thesis here. Caveats: No evidence were kept after recent evidence filtering. Cannot rely on dropped 2025 evidence for a current ranking. Company-category relevance is not sufficient for a directional opportunity thesis. |